Neurocrine Biosciences (NBIX) EBT Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 53.36% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.84% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 33.51% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 63.73% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -6.95% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -76.13% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -118.90% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 152.43% |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 100.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.73% |
| Dec 31, 2025 | 26.63% |
| Sep 30, 2025 | 43.91% |
| Jun 30, 2025 | 106.81% |
| Mar 31, 2025 | -11.77% |
| Dec 31, 2024 | 139.76% |
| Sep 30, 2024 | 84.10% |
| Jun 30, 2024 | 19.69% |
| Mar 31, 2024 | 8.25% |
| Dec 31, 2023 | 68.13% |
| Sep 30, 2023 | 59.06% |
| Jun 30, 2023 | 13.48% |
| Mar 31, 2023 | -66.98% |
| Dec 31, 2022 | 45.09% |
| Sep 30, 2022 | 18.79% |
| Jun 30, 2022 | -34.76% |
| Mar 31, 2022 | 30.23% |
| Dec 31, 2021 | -39.85% |
| Sep 30, 2021 | -15.62% |
| Jun 30, 2021 | 127.18% |